Savina Jaeger
Senior Director, Innovative Statistics
Dr. Savina Jaeger is Senior Director, Innovative Statistics at Cytel. Savina has 22 years of experience applying statistical innovation to research and drug development across academia and industry. She is a data‑driven decision-maker with extensive expertise supporting and managing biostatistics strategy in clinical development across oncology, rare diseases, ophthalmology, neuroscience, metabolic disorders, and infectious diseases in both small biotechnology companies and global pharmaceutical organizations.
Savina brings significant experience leveraging a wide range of genomics and clinical data to advance scientific research and clinical development. She has served in roles spanning individual contributor to group leader at large pharmaceutical companies — including Pfizer, Novartis, Takeda, and Bayer — and most recently has held VP of Biometrics positions in biotechnology organizations.
She has a proven track record in designing pivotal and adaptive clinical trials and supporting global regulatory interactions with the FDA, EMA, PMDA, and CDRH. Savina also has extensive experience building and leading multi‑functional teams, integrating data management and analytics platforms, and delivering regulatory‑grade clinical evidence from early development through approval and commercialization.
Savina is recognized for her cross‑functional collaboration, scientific rigor and mentorship, operational excellence, and commitment to innovation.
Before joining large pharma and biotech companies, Savina was a Postdoctoral Research Fellow at Harvard Medical School, where she collaborated with scientists and physicians and co‑authored research papers in leading journals such as Science, Nature Methods, Cell, Molecular Cell, Cancer Cell, Biological Psychiatry, and Genomics.
Savina earned her PhD in Mathematics from Boston University and her Master’s degree in Applied Mathematics from Sofia University.
“What I do not know, I do not think I know.” Plato, Apology, 21d.
